JAGX

Conviction 67HealthcareScan · Thu, Jun 25, 2026

JAGX$2.73+1.87%

ResistanceSupportVol 14

Vol MA14 107.46K

Mar 26Apr 14May 1May 19Jun 8Jun 25

Jaguar Health, Inc.PHARMACEUTICAL PREPARATIONSwww.jaguar.health ↗

Price2.73

Change+1.87%

Gap+2.05%

Rel volume0.10×

Avg volume91.97K

Avg $ vol245.14K

SMA 202.79

SMA 502.59

SMA 2001.55

Price vs 50+5.21%

Price vs 200+76.02%

MA stackbullish

50/200 cross—

Supertrenddown · 3.32

RSI (14)50

MACD hist-0.04

MACD cross—

Stoch %K / %D69 / 57

ADX (14)11

+DI / −DI25 / 21

RSI divergence—

MACD divergenceBullish

ATR %+13.49%

ADR %10.31%

52w high6.96

52w low0.2250

From 52w high-60.78%

Above 52w low+1113.33%

New 52w highNo

SqueezeOff

Bollinger width47.87%

%B0.45

Donchian pos39.61%

Donchian high3.66

Donchian low2.12

AVWAP (52w high)3.23

vs AVWAP high-15.45%

AVWAP (52w low)2.80

vs AVWAP low-2.67%

OBV trendFlat

Chaikin MF (20)0.06

Today vs 20d0.10×

Avg vol (14d)107.46K

Avg vol (20d)91.97K

Avg $ vol (20d)245.14K

Market cap467.79M

RS 3m (vs SPY)+562.47%

RS 6m (vs SPY)+121.32%

RS line new highNo

Trend template5/8

Technical rank78.6

1 week+14.71%

1 month-12.22%

3 months+556.25%

6 months+129.41%

1 year-10.49%

YTD+173.68%

P/E-8.73

P/B21.70

P/S—

P/FCF-19.74

EPS-22.97

Div yield—

ROE-248.58%

ROA-143.12%

Debt/Eq0.50

Current0.50

EV/EBITDA-10.71

Gross margin—

Net margin—

Rev growth—

EPS growth-39.18%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value471.28M

Revenue883.85K

Net income-9.5M

Gross profit—

Free cash flow-23.7M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out603.13K

Employees47

ListedWed, May 13, 2015

Free float12.41M

Float %88.4%

Short interest64.06K

Days to cover0.4d

Short volume18.4%

Squeeze score3 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeB

Conviction67 / 100

Pattern quality—

Tech rank78.6 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance4.06

Support2.33

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Sep 30, 2025 · quarterly.

Congress activity

Disclosed STOCK Act trades in JAGX

All disclosures →

No recent disclosed trades by Congress in JAGX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in JAGX

No recent insider (Form 4) filings in JAGX. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in JAGX · 7 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.